The monoclonal antibody cocktail was recently approved in India. As per reports, the treatment shows promising results in a 65-year-old administered with it.
The Indian market will soon have a low cost COVID-19 antibody detection test thanks to the efforts of scientists at DRDO. Read on to know more.
With RT-PCR tests failing to detect some COVID-19 variants, more people are demanding CT scans on testing positive. Is this really necessary?
There is now an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to COVID-19. Read on to know more.
The Covid-19 testing platform can identify the presence of two Covid-19 antibodies, spike S1 protein and receptor-binding domain (RBD), from a very small drop of blood.
To enable rapid COVID-19 testing, the University of Birmingham researchers have developed a new method called "Reverse Transcriptase Free EXPAR (RTF-EXPAR) testing." Read to know more about this new test.
The monoclonal antibody cocktail was recently approved in India. As per reports, the treatment shows promising results in a 65-year-old administered with it.
The Indian market will soon have a low cost COVID-19 antibody detection test thanks to the efforts of scientists at DRDO. Read on to know more.
With RT-PCR tests failing to detect some COVID-19 variants, more people are demanding CT scans on testing positive. Is this really necessary?
There is now an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to COVID-19. Read on to know more.
The Covid-19 testing platform can identify the presence of two Covid-19 antibodies, spike S1 protein and receptor-binding domain (RBD), from a very small drop of blood.
To enable rapid COVID-19 testing, the University of Birmingham researchers have developed a new method called "Reverse Transcriptase Free EXPAR (RTF-EXPAR) testing." Read to know more about this new test.
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Refresh Page